Preparing storing beyond use dating of buffered lidocaine
Thus, there is an urgent need for improved therapies to treat bacterial infections.
 Mycosis is a condition in which fungi pass the resistance barriers of the human or animal body and establish infections.
 The embodiments of the present invention also involve mechanical or physical treatments that cause integumental perturbation (e.g., dermabrasion) which may be used as part of a treatment for modulating hair growth in human subjects.
The combination treatment(s) may be administered concurrently with, or during the "holidays" between, cycles of intermittent lithium treatments; or concurrently with, or before and/or after the pulse lithium treatment.
Anti-fungal agents that are currently used to treat cutaneous fungal infections include imidazoles, polyenes, thiocarbamates, ciclopirox, terbinafme, amorolfine, undecylenic alkanolamide and griseofulvin.
Cutaneous fungal infections can be persistent and can often reoccur.
To date, no antimicrobial class of compounds are available that effectively treat wound-related biofilms.The lithium treatment(s) can be used in combination with other treatments, such as mupirocin, for treating microbial infections. Microbial infections can also arise as a part of systemic infection.The combination treatment(s) may be administered concurrently with, or before and/or after the lithium treatment.  Bacterial infections can be caused by several types of bacteria, including Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Propionibacterium acnes, Staphylococcus epidermidis, Acinetobacter baumannii, Klebsiella pneumoniae, Enterobacter cloacae, Streptococcus pyogenes, corynebacterium species, enterococci, Proteus mirabilis, group D streptococci, other gram-positive aerobes, and Bacteroides fragilis. Acne is a disease of the pilosebaceous units in the skin.